Shanying Gui

HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes

Kate Chatfield‐Reed, Shanying Gui, Wendi Quinn O’Neill et al. · Oral Oncology · 2019 · 41 citations · Full text

Molecular Virology, Viral Persistence, Human Papillomavirus Vaccines +11

Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma

Tatevik Broutian, Bo Jiang, Jingfeng Li et al. · Cancer Letters · 2020 · 16 citations · Full text

Human Papillomavirus Vaccines, Medicine, Pathology +12

Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC

Shanying Gui, Wendi Quinn O’Neill, Theodoros N. Teknos et al. · Journal for ImmunoTherapy of Cancer · 2021 · 13 citations · Full text

Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma

Wendi Quinn O’Neill, Xiujie Xie, Shanying Gui et al. · Cancers · 2022 · 13 citations · Full text

Immunology, Pathology, Tumor-immune Microenvironment +20

p53 functional states are associated with distinct aldehyde dehydrogenase transcriptomic signatures

Shanying Gui, Xiujie Xie, Wendi Quinn O’Neill et al. · Scientific Reports · 2020 · 12 citations · Full text